These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8769635)
21. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs. Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802 [TBL] [Abstract][Full Text] [Related]
22. Nonvirion antigens produced by herpes simplex viruses 1 and 2. Tarro G; Sabin AB Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219 [TBL] [Abstract][Full Text] [Related]
23. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. Weinberg A; Merigan TC J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice. Nagafuchi S; Oda H; Mori R; Taniguchi T J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089 [No Abstract] [Full Text] [Related]
35. [Infections due to herpes simplex virus, recurrent disease and problem of latency]. Terni M G Mal Infett Parassit; 1971 Jul; 23(7):433-67. PubMed ID: 4334706 [No Abstract] [Full Text] [Related]